pqq cofactor has been researched along with malondialdehyde in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Karliner, JS; Teerlink, JR; Zhou, HZ; Zhu, BQ | 1 |
| Cecchini, G; Karliner, JS; Li, L; Simonis, U; Teerlink, JR; Zhou, HZ; Zhu, BQ | 1 |
| Bauerly, K; Chowanadisai, W; Graham, J; Harris, C; Havel, PJ; Karliner, JS; Rucker, RB; Satre, M; Tchaparian, E | 1 |
| Aoki, Y; Geng, C; Gong, D; Jiang, L; Nakano, M; Zhong, L | 1 |
| Ding, F; Jiang, C; Ke, K; Qin, J; Zhang, J; Zhang, Q | 1 |
| Ding, F; Dong, X; Gao, X; Ji, J; Qin, J; Wu, M; Yu, S; Zhang, J; Zhang, Q; Zhang, Y; Zhou, L | 1 |
| Long, C; Qi, GH; Samuel, KG; Sun, LL; Wang, J; Wu, SG; Xu, L; Yue, HY; Zhang, HJ | 1 |
| Huang, J; Jiang, S; Li, J; Lin, X; Tang, Y; Yang, F | 1 |
1 trial(s) available for pqq cofactor and malondialdehyde
| Article | Year |
|---|---|
Dietary supplementation of pyrroloquinoline quinone disodium protects against oxidative stress and liver damage in laying hens fed an oxidized sunflower oil-added diet.
Topics: Animal Feed; Animals; Antioxidants; Chickens; Diet; Dietary Supplements; Female; Glutathione; Glutathione Peroxidase; Lipid Peroxidation; Liver; Malondialdehyde; Oviposition; Oxidation-Reduction; Oxidative Stress; Plant Oils; PQQ Cofactor; Sunflower Oil; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Vitamin E | 2016 |
7 other study(ies) available for pqq cofactor and malondialdehyde
| Article | Year |
|---|---|
Pyrroloquinoline quinone (PQQ) decreases myocardial infarct size and improves cardiac function in rat models of ischemia and ischemia/reperfusion.
Topics: Animals; Body Weight; Disease Models, Animal; Dose-Response Relationship, Drug; Heart Function Tests; Injections, Intraperitoneal; Injections, Intravenous; Malondialdehyde; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; PQQ Cofactor; Rats; Ventricular Fibrillation | 2004 |
Comparison of pyrroloquinoline quinone and/or metoprolol on myocardial infarct size and mitochondrial damage in a rat model of ischemia/reperfusion injury.
Topics: Adrenergic beta-Antagonists; Animals; Antioxidants; Body Weight; Cardiotonic Agents; Creatine Kinase; Drug Interactions; Hemodynamics; Lipid Peroxidation; Male; Malondialdehyde; Metoprolol; Mitochondria, Heart; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Oxidative Stress; Oxygen Consumption; PQQ Cofactor; Rats; Rats, Sprague-Dawley; Ventricular Fibrillation | 2006 |
Altering pyrroloquinoline quinone nutritional status modulates mitochondrial, lipid, and energy metabolism in rats.
Topics: Animals; Body Weight; Diabetes Mellitus, Type 2; Disease Models, Animal; Energy Metabolism; Glucose; Heart; Heart Function Tests; Lipid Peroxidation; Lipids; Malondialdehyde; Mitochondria; Myocardial Infarction; Myocardial Reperfusion Injury; Nutritional Status; PQQ Cofactor; Rats; Rats, Sprague-Dawley; Survival Rate | 2011 |
Effect of pyrroloquinoline quinone on neuropathic pain following chronic constriction injury of the sciatic nerve in rats.
Topics: Administration, Oral; Analgesics; Animals; Anti-Inflammatory Agents; Antioxidants; Behavior, Animal; Biomarkers; Constriction; Disease Models, Animal; Hyperalgesia; Inflammation Mediators; Lipid Peroxidation; Male; Malondialdehyde; Muscle, Skeletal; Muscular Atrophy; Oxidative Stress; Pain Measurement; Pain Threshold; PQQ Cofactor; Rats; Rats, Sprague-Dawley; Reaction Time; Sciatic Nerve; Sciatica; Time Factors; Tumor Necrosis Factor-alpha | 2012 |
Involvement of ERK1/2 pathway in neuroprotective effects of pyrroloquinoline quinine against rotenone-induced SH-SY5Y cell injury.
Topics: Apoptosis; bcl-2-Associated X Protein; Cell Line, Tumor; Cell Survival; DNA, Mitochondrial; Electron Transport Complex I; Glutathione; Humans; Malondialdehyde; MAP Kinase Signaling System; Mitochondria; NADH Dehydrogenase; Neuroprotective Agents; Parkinsonian Disorders; PQQ Cofactor; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Rotenone; Superoxide Dismutase | 2014 |
Pyrroloquinoline quinone-conferred neuroprotection in rotenone models of Parkinson's disease.
Topics: Animals; Antioxidants; Cell Line; Cell Survival; Gene Expression Regulation; Glutathione; Humans; Malondialdehyde; Neuroprotective Agents; Parkinson Disease, Secondary; PQQ Cofactor; Rats; Rotenone; Superoxide Dismutase; Tyrosine 3-Monooxygenase; Vesicular Monoamine Transport Proteins | 2015 |
Ameliorate effect of pyrroloquinoline quinone against cyclophosphamide-induced nephrotoxicity by activating the Nrf2 pathway and inhibiting the NLRP3 pathway.
Topics: Animals; Antioxidants; Blood Urea Nitrogen; Body Weight; Creatinine; Cyclophosphamide; Cytokines; Inflammation; Inflammation Mediators; Kidney; Kidney Diseases; Male; Malondialdehyde; Mice, Inbred ICR; Models, Biological; NF-E2-Related Factor 2; NLR Family, Pyrin Domain-Containing 3 Protein; Organ Size; PQQ Cofactor; Signal Transduction | 2020 |